SCHEMBL5887285

SCHEMBL5887285

COC1=CC[CH]C(c2cccc(OC)c2)=C1c1ccc(C)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALKBH3 Q96Q83 1/20 0.44
ACHE P22303 1/20 0.39
KDM4E B2RXH2 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MAOB P27338 4/20 0.38
NPC1 O15118 2/20 0.37
ALDH1A1 P00352 1/20 0.37
TP53 P04637 1/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
NFKB1 P19838 1/20 0.37
RAB9A P51151 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6047660 0.91 ALDH1A1 (0.40) CYP1A2CYP3A4MAPTCYP2C9CYP2C19
SCHEMBL5887353 0.89 MEN1 (0.35) ALKBH3ACHEKDM4ENPC1TP53
SCHEMBL5887288 0.88 ALDH1A3 (0.41) KDM4EMAOBALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL5887105 0.86 ESR2 (0.35) MAPTNPC1TP53SMN1; SMN2
SCHEMBL5887287 0.85 ACHE (0.46) ALKBH3ACHEKDM4EMAPTNPSR1
SCHEMBL5887320 0.84 ACHE (0.33) ALKBH3ACHECYP2C9CYP2C19NPC1
SCHEMBL5887499 0.83 ALKBH3 (0.41) ALKBH3ACHEKDM4ECYP1A2CYP3A4
SCHEMBL5887199 0.81 KMT2A (0.35) ACHENPC1ALDH1A1TP53HPGD
SCHEMBL5887303 0.79 CASR (0.39) MAPTMAOBSMN1; SMN2
SCHEMBL5887347 0.78 MEN1 (0.35) MAPTTP53MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 US claimed
JP-2006501194-A 2006-01-12 JP claimed
EP-1525190-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-04-27 EP claimed
WO-2004007463-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-01-22 WO claimed